Duane Mancini, M. Sc., Master of Science in Medical Chemistry

President and Founder

Project Medtech

Cleveland, Ohio United States

About Me

I am originally trained as a chemist but got my start in the medical device space with NAMSA working with clients on biological safety strategy. I moved within NAMSA to their regulatory, reimbursement, and clinical strategy group to learn and support clients in that space. Because of this unique end-to-end background, I was asked to work with our start-up clients to help develop and execute get-to-market strategies to save time and cost to market. I currently work for Covance on the Medical Device and Diagnostic team. I also host a podcast called Project Medtech. Project Medtech is an interview style podcast with leading experts in the medical device industry as they share success stories, advice, pitfalls, trends and more for innovators in the MedTech industry.

Interested in solutions for:

For my community

I am looking for healthcare innovations:

No project created yet. Lets change that!
Discover Projects

No comments on any project yet. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No project reviewed yet. Lets change that!
Discover Projects

Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.